FDA advises needle-free device manufacturers that "regulation" on injectors comes from many sources
This article was originally published in Clinica
Executive Summary
Speaking at last week's Management Conference on Needle-Free and Auto Injectors in London, Tim Ulatowski of the US FDA reminded delegates that, apart from the formal approval from the federal agency, a number of other interest groups, with greater or lesser legal status, also monitor needle-free devices.